493 related articles for article (PubMed ID: 30530166)
21. Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation.
Guo W; Liu W; Jin B; Geng J; Li J; Ding H; Wu X; Xu Q; Sun Y; Gao J
Int Immunopharmacol; 2015 Feb; 24(2):232-238. PubMed ID: 25523461
[TBL] [Abstract][Full Text] [Related]
22. Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition.
Guo W; Hu S; Elgehama A; Shao F; Ren R; Liu W; Zhang W; Wang X; Tan R; Xu Q; Sun Y; Jiao R
J Pharmacol Sci; 2015 Oct; 129(2):101-6. PubMed ID: 26320672
[TBL] [Abstract][Full Text] [Related]
23. Using Network Pharmacology for Systematic Understanding of Geniposide in Ameliorating Inflammatory Responses in Colitis Through Suppression of NLRP3 Inflammasome in Macrophage by AMPK/Sirt1 Dependent Signaling.
Pu Z; Liu Y; Li C; Xu M; Xie H; Zhao J
Am J Chin Med; 2020; 48(7):1693-1713. PubMed ID: 33202149
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
[TBL] [Abstract][Full Text] [Related]
25. Protective role of liriodendrin in mice with dextran sulphate sodium-induced ulcerative colitis.
Zhang Z; Yang L; Wang B; Zhang L; Zhang Q; Li D; Zhang S; Gao H; Wang X
Int Immunopharmacol; 2017 Nov; 52():203-210. PubMed ID: 28941417
[TBL] [Abstract][Full Text] [Related]
26. Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone.
Wu XF; Ouyang ZJ; Feng LL; Chen G; Guo WJ; Shen Y; Wu XD; Sun Y; Xu Q
Toxicol Appl Pharmacol; 2014 Nov; 281(1):146-56. PubMed ID: 25448682
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Th17 cell differentiation via sphingosine-1-phosphate receptor 2 by cinnamaldehyde can ameliorate ulcerative colitis.
Qu SL; Chen L; Wen XS; Zuo JP; Wang XY; Lu ZJ; Yang YF
Biomed Pharmacother; 2021 Feb; 134():111116. PubMed ID: 33341041
[TBL] [Abstract][Full Text] [Related]
28. Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation.
Mai CT; Wu MM; Wang CL; Su ZR; Cheng YY; Zhang XJ
Mol Immunol; 2019 Jan; 105():76-85. PubMed ID: 30496979
[TBL] [Abstract][Full Text] [Related]
29. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation.
Sun Y; Zhao Y; Yao J; Zhao L; Wu Z; Wang Y; Pan D; Miao H; Guo Q; Lu N
Biochem Pharmacol; 2015 Mar; 94(2):142-54. PubMed ID: 25677765
[TBL] [Abstract][Full Text] [Related]
30. Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway.
Yao H; Yan J; Yin L; Chen W
Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):437-446. PubMed ID: 35293848
[TBL] [Abstract][Full Text] [Related]
31. Sulforaphane decreases oxidative stress and inhibits NLRP3 inflammasome activation in a mouse model of ulcerative colitis.
Zhou ZJ; Dong JY; Qiu Y; Zhang GL; Wei K; He LH; Sun YN; Jiang HZ; Zhang SS; Guo XR; Wang JY; Chen DP
Biomed Pharmacother; 2024 Jun; 175():116706. PubMed ID: 38713944
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of Amauroderma rugosum on dextran sulfate sodium-induced ulcerative colitis through the regulation of macrophage polarization and suppression of oxidative stress.
Li J; Luo X; Shiu PH; Cheng Y; Nie X; Rangsinth P; Lau BWM; Zheng C; Li X; Li R; Lee SM; Fu C; Seto SW; Zhang J; Leung GP
Biomed Pharmacother; 2024 Jul; 176():116901. PubMed ID: 38878683
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism of Shenling Baizhu Powder on treatment of ulcerative colitis based on NLRP3 inflammatory].
Liu YH; Rong ZL; Zhu HY; Li YT; You Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5863-5871. PubMed ID: 36472005
[TBL] [Abstract][Full Text] [Related]
35. PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis.
Han L; Hao Y; Wu X; Hu D
Dis Markers; 2022; 2022():2329904. PubMed ID: 36061354
[TBL] [Abstract][Full Text] [Related]
36. Protective Effect of D-Carvone against Dextran Sulfate Sodium Induced Ulcerative Colitis in Balb/c Mice and LPS Induced RAW Cells via the Inhibition of COX-2 and TNF-α.
Zhu X; Wang G; Wu S; Li C
J Environ Pathol Toxicol Oncol; 2020; 39(3):235-245. PubMed ID: 32865915
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice.
Sangaraju R; Nalban N; Alavala S; Rajendran V; Jerald MK; Sistla R
Inflamm Res; 2019 Aug; 68(8):691-704. PubMed ID: 31147743
[TBL] [Abstract][Full Text] [Related]
38. Stevioside, a diterpenoid glycoside, shows anti-inflammatory property against Dextran Sulphate Sodium-induced ulcerative colitis in mice.
Alavala S; Sangaraju R; Nalban N; Sahu BD; Jerald MK; Kilari EK; Sistla R
Eur J Pharmacol; 2019 Jul; 855():192-201. PubMed ID: 31075241
[TBL] [Abstract][Full Text] [Related]
39. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
Mei Y; Fang C; Ding S; Liu X; Hu J; Xu J; Mei Q
Int Immunopharmacol; 2019 Oct; 75():105776. PubMed ID: 31351364
[TBL] [Abstract][Full Text] [Related]
40. Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway.
Zheng J; Wang S; Zhang T; Li H; Zhu M; Wei X; Ge Y; Yang X; Zhang S; Xu H; Duan Y; Liu L; Chen Y
Int Immunopharmacol; 2023 Jul; 120():110378. PubMed ID: 37244119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
